| Phase 3 |
| NCT04210115 |
Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma… |
Esophageal Squamous Cell Carcinoma (ESCC) |
Active, Not Recruiting |
| NCT04607421 |
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With… |
Neoplasms |
Active, Not Recruiting |
| Phase 2 |
| NCT03977233 |
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer |
Pancreatic Ductal Adenocarcinoma (PDAC) |
Recruiting |
| NCT04150640 |
Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in… |
Esophageal Adenocarcinoma |
Recruiting |
| NCT07484724 |
A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With… |
Advanced Esophageal Squamous Cell Carcinoma |
Recruiting |
| NCT06535607 |
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in… |
Sub-study 1 Cervical Cancer (Volrustomig Monotherapy) |
Recruiting |
| NCT04229459 |
Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell… |
Esophageal Squamous Cell Carcinoma |
Active, Not Recruiting |
| NCT07474727 |
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer |
Colorectal Cancer |
Not Yet Recruiting |
| NCT05945823 |
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid… |
Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer |
Active, Not Recruiting |
| Phase 1/2 |
| NCT07056777 |
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard… |
Gastrointestinal Cancer |
Recruiting |
| NCT06741644 |
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors |
Advanced Solid Tumors |
Recruiting |
| NCT06771622 |
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With… |
Solid Cancer |
Active, Not Recruiting |
| NCT04083599 |
GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors |
Malignant Solid Tumor |
Active, Not Recruiting |
| Phase 1 |
| NCT07532902 |
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer |
Diffuse Pleural Mesothelioma |
Recruiting |
| NCT07024615 |
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With… |
Pancreatic Ductal Adenocarcinoma |
Recruiting |